Formula for success? | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website


    30% off entry-level Bronze Patron packages (retails for $250 - reduced to $175)
    includes 2 yrs of Premium Plus service & locks in 30% discount for any future Patron upgrades

    Only 35 spots available (first come, first served)

    BONUS: Purchase your spot over the next 24 hrs & get an extra year of Premium Plus service absolutely free! 

    CLICK HERE to become a Bronze Patron now 

IDRA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1515 of 1614  at  9/2/2019 9:49:58 PM  by


 In response to msg 1512 by  clsm
view thread

Re: Formula for success?

Rosenberg is wrong. Itís not like making a vaccine to a foreign pathogen with no self antigens. Doesnít have a damn thing to do with volume of DCís and Tcells. You are trying to design a vaccine to target cancer specific antigens that are located in very low ratio right next to very high ratio of self antigens. In addition, Treg affinity for self antigens is much higher than DCís...therefore they will declare tolerance and interfere with the start of the antigens presenting cascade with CTLA-4 locking up the CD80/86 ligands.

Now how to overcome all the above? Itís been figured out. Think points in the cascade you need to address with what and when ....when making a vaccine. Can you spot one obvious thing all prior vaccines have left out? Well ďobviousĒ to me.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 141
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by